---
acquisition_date: '2025-10-21T16:20:54.137314'
acquisition_method: paperscraper_automated
audience:
- professional
- researcher
authors: '[''YanCheng'', ''YouxuanLing'', ''JoelScholten'', ''DavidAtkins'', ''Joseph
  LGoulet'', ''Helen MSheriff'', ''Charity JMorgan'', ''Mary RLee'', ''Cherina MCyborski'',
  ''Jose DVargas'', ''FriedhelmSandbrink'', ''VamseePotluri'', ''QingZeng-Treitler'',
  ''AliAhmed'', ''CharlesFaselis'']'
conditions:
- tourette_syndrome
- adhd
- asd
content_type: research_paper
doi: 10.1016/j.amjmed.2025.10.010
journal: The American journal of medicine
keywords:
- tourette_syndrome
- adhd
- asd
- growth_hormones
- behavioral_therapy
- adhd
- pubmed
patient_friendly: false
primary_category: adhd
publication_date: '2025-10-20'
reading_level: academic
search_priority: standard
search_query: attention deficit hyperactivity disorder
search_tags:
- tourette_syndrome
- adhd
- asd
- growth_hormones
- behavioral_therapy
- adhd
- pubmed
- research
- academic
source: PUBMED via Paperscraper
title: Patterns and Trends in Prevalent Central Nervous System Stimulant Use in US
  Veterans with Traumatic Brain Injury.
topics:
- tourette_syndrome
- adhd
- asd
- growth_hormones
- behavioral_therapy
type: research_paper
---

# Patterns and Trends in Prevalent Central Nervous System Stimulant Use in US Veterans with Traumatic Brain Injury.

**Authors:** ['YanCheng', 'YouxuanLing', 'JoelScholten', 'DavidAtkins', 'Joseph LGoulet', 'Helen MSheriff', 'Charity JMorgan', 'Mary RLee', 'Cherina MCyborski', 'Jose DVargas', 'FriedhelmSandbrink', 'VamseePotluri', 'QingZeng-Treitler', 'AliAhmed', 'CharlesFaselis']

**Journal:** The American journal of medicine

**Publication Date:** 2025-10-20

**DOI:** 10.1016/j.amjmed.2025.10.010

## Abstract

Patients with chronic mild traumatic brain injury (TBI) may experience cognitive and behavioral symptoms resembling attention-deficit/hyperactivity disorder (ADHD). Central nervous system (CNS) stimulants, used for ADHD, are not recommended for TBI but are prescribed off-label. We examined patterns and trends of prevalent stimulant use among Veterans with TBI. Of the 966,953 U.S. Veterans with TBI (2001-2023), 11,710 were prevalent users of CNS stimulants, defined as prescription fills during six months before first TBI diagnosis in Veterans Affairs (VA) healthcare system. Patients were categorized into 2001-2014 (combat in Iraq and Afghanistan wars), 2015-2019 (post-combat), and 2020-2023 (COVID-19 pandemic). Prevalence (95% CI) of stimulant use per 10,000 Veterans with TBI and yearly temporal trends were estimated. Estimates during 2015-2019 and 2020-2023 were compared with 2001-2014 using absolute standardized differences (ASD; â‰¥10% suggesting clinically significant difference). Prevalent CNS stimulant use (95% CI) during 2001-2014, 2015-2019, and 2020-2023 were 83 (81-85), 150 (145-155; ASD=6%) and 194 (188-200; ASD=11%) per 10,000 Veterans, respectively. Respective rates in subgroups with opioid use disorder were 174 (165-182), 351 (333-369; ASD=11%), and 457 (434-480; ASD=16%), and attention-deficit/hyperactivity disorder were 2054 (1934-2174), 1764 (1681-1847; ASD=7%), and 1950 (1871-2029; ASD=3%). Prevalent CNS stimulant use among Veterans with TBI is low, despite higher temporal trends, including in high-risk subgroups. Future studies need to examine patterns and trends of incident CNS stimulant use, as well as their safety and effectiveness.

---

## Research Details

**Source:** PUBMED
**Category:** adhd
**Primary Topics:** tourette_syndrome, adhd, asd, growth_hormones, behavioral_therapy
**Search Query:** attention deficit hyperactivity disorder
**Acquisition Date:** 2025-10-21

*This paper was automatically acquired and processed for the neurodevelopmental disorders knowledge base.*
